Therapeutics Development Center

Grants and Contracts Details


We have now enrolled our first subject in Vertex. In addition, we are the first site to be approved by the sponsor to enroll for Nivalis-SNO6 and we screened already screened two subjects and have two more scheduled for screening. We are also ready to enroll for the Solution study and await drug availability on IGNITE.
Effective start/end date1/1/1412/31/16


  • Cystic Fibrosis Foundation Therapeutics Incorporated: $90,628.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.